Method of using IL-11 for treating spondyloarthropies
OwnerJames Keith, Paul Schendelinventors
Life of this patent
Estimating the term…
Abstract
Provided by the present invention are methods of treating a variety of disorders including AIDS, arthritis (rheumatoid arthritis, osteoarthritis, spondyloarthropathies), antibiotic induced diarrheal diseases (Clostridium difficile), multiple sclerosis, osteoporosis, gingivitis, peptic ulcer disease, esophagitis, diabetes, retinitis, uveitis, reperfusion injury after myocardial infarction (MI) or cerebral vascular accident (CVA), aphthous ulcers (oral), atherosclerosis (plaque rupture), prevention of minor metastases, asthma, preeclampsia, and allergic disorders such as rhinitis, conjunctivitis, and urticaria.
Claims2
A method of treating spondyloarthropies, comprising administering a pharmaceutically effective amount of IL-11.
The method of claim 2 wherein the amount of IL-11 is between 1 and 100 .mu.g/kg body weight.
Dependencies are inferred from the claim text.